Walgreen Crunches Numbers from USA Drug Buy

According to Walgreen Co.'s earnings report for its fiscal first quarter, which ended Nov. 30, buying USA Drug from Stephen L. LaFrance Holdings Inc. cost Walgreen's $416 million.

Want the Full Article?

Get Unlimited Archive Access for $19.95 per Year

Readers must pay to access stories older than 20 days.

Purchase Now

Already have archive access? Login to view this article.